Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Depreciation and Depletion (2016 - 2017)

Historic Depreciation and Depletion for Prestige Consumer Healthcare (PBH) over the last 7 years, with Q1 2017 value amounting to $1.7 million.

  • Prestige Consumer Healthcare's Depreciation and Depletion rose 1333.33% to $1.7 million in Q1 2017 from the same period last year, while for Mar 2017 it was $6.0 million, marking a year-over-year increase of 1538.46%. This contributed to the annual value of $9.7 million for FY2025, which is 1829.27% up from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Depreciation and Depletion stood at $1.7 million for Q1 2017, which was up 1333.33% from $1.3 million recorded in Q4 2016.
  • Prestige Consumer Healthcare's 5-year Depreciation and Depletion high stood at $1.7 million for Q1 2017, and its period low was $500000.0 during Q3 2013.
  • Moreover, its 5-year median value for Depreciation and Depletion was $1.2 million (2015), whereas its average is $1.1 million.
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Depreciation and Depletion surged by 50000.0% in 2013, and later plummeted by 909.09% in 2014.
  • Over the past 5 years, Prestige Consumer Healthcare's Depreciation and Depletion (Quarter) stood at $1.1 million in 2013, then dropped by 9.09% to $1.0 million in 2014, then rose by 20.0% to $1.2 million in 2015, then increased by 8.33% to $1.3 million in 2016, then surged by 30.77% to $1.7 million in 2017.
  • Its Depreciation and Depletion stands at $1.7 million for Q1 2017, versus $1.3 million for Q4 2016 and $1.5 million for Q3 2016.